Material Event Form 8 K

Item 8.01. Other Events.

As previously disclosed, on August 13, 2024, Syra Health Corp. (the "Company") received a written notice (the "Notice") from the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it was not in compliance with Nasdaq Listing Rule 5550(b)(1), or 5550(b)(2), or 5550(b)(3) (the "Rules"), since it did not comply with the minimum $2.5 million stockholders' equity, or $35 million market value of listed securities, or $500,000 of net income from continuing operations requirements.

Based on Form 10-Q filed October 29, 2024, evidencing stockholders' equity of $3,330,653, as of September 30, 2024, the Staff has determined that the Company complies with the Rules and this matter is now closed.